Expression of endoplasmic reticulum molecular chaperone Grp78 in human lung cancer and its clinical significance

Lung Cancer - Tập 49 - Trang 55-62 - 2005
Hidetaka Uramoto1, Kenji Sugio1, Tsunehiro Oyama1, Shoji Nakata1, Kenji Ono1, Takashi Yoshimastu1, Masaru Morita1, Kosei Yasumoto1
1Second Department of Surgery, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, Japan

Tài liệu tham khảo

Parkin, 2001, Cancer burden in the year 2000. The global picture, Eur J Cancer, S4, 10.1016/S0959-8049(01)00267-2

Mountain, 1997, Revisions in the International System for Staging Lung Cancer, Chest, 111, 1710, 10.1378/chest.111.6.1710

Martini, 1995, Incidence of local recurrence and second primary tumors in resected stage I lung cancer, J. Thorac. Cardiovasc. Surg, 109, 120, 10.1016/S0022-5223(95)70427-2

Strauss, 1995, Molecular and pathologic markers in stage I non-small cell carcinoma of the lung, J Clin Oncol, 13, 1265, 10.1200/JCO.1995.13.5.1265

Fukuyama, 1997, K-ras and p53 mutations are an independent unfavourable prognostic indicator in patients with non-small-cell lung cancer, Br J Cancer, 75, 1125, 10.1038/bjc.1997.194

Sugio, 1992, ras Gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis, Cancer Res, 52, 2903

Sugio, 1993, Different site mutation of the K-ras gene in a patient with metachronous double lung cancers, Anticancer Res, 13, 2469

Osaki, 1995, Serum level and tissue expression of c-erbB-2 protein in lung adenocarcinoma, Chest, 108, 157, 10.1378/chest.108.1.157

Oyama, 1998, p53 Alteration, proliferating cell nuclear antigen, and nucleolar organizer regions in thymic epithelial tumors, Int J Mol Med, 1, 823

Dobashi, 1997, Micrometastatic P53-positive cells in the lymph nodes of non-small-cell lung cancer: prognostic significance, J Thorac Cardiovasc Surg, 114, 339, 10.1016/S0022-5223(97)70178-8

Kaufman, 2002, Orchestrating the unfolded protein response in health and disease, J Clin Invest, 110, 1389, 10.1172/JCI0216886

Mori, 2000, Tripartite management of unfolded proteins in the endoplasmic reticulum, Cell, 101, 451, 10.1016/S0092-8674(00)80855-7

Urano, 2000, IRE1 and efferent signaling from the endoplasmic reticulum, J Cell Sci, 21, 3697, 10.1242/jcs.113.21.3697

Patil, 2001, Intracellular signaling from the endoplasmic reticulum to the nucleus: the unfolded protein response in yeast and mammals, Curr Opin Cell Biol, 13, 349, 10.1016/S0955-0674(00)00219-2

Okada, 2002, Distinct roles of activating transcription factor 6 (ATF6) and double-stranded RNA-activated protein kinase-like endoplasmic reticulum kinase (PERK) in transcription during the mammalian unfolded protein response, Biochem J, 366, 585, 10.1042/bj20020391

Yoshida, 2000, ATF6 activated by proteolysis binds in the presence of NF-Y (CBF) directly to the cis-acting element responsible for the mammalian, Mol Cell Biol, 20, 6755, 10.1128/MCB.20.18.6755-6767.2000

Yoshida, 2001, XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor, Cell, 107, 881, 10.1016/S0092-8674(01)00611-0

Uramoto, 1999, Fas expression in non-small cell lung cancer: its prognostic effect in completely resected stage III patients, Eur J Cancer, 35, 1462, 10.1016/S0959-8049(99)00157-4

Shuda, 2003, Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcinogenesis, J Hepatol, 38, 605, 10.1016/S0168-8278(03)00029-1

Kaplan, 1958, Non-parametric estimation from incomplete observations, J Am Stst Assoc, 53, 457, 10.1080/01621459.1958.10501452

Peto, 1977, Design and analysis of randomised clinical trials requiring prolonged observation of each patient, Br J Cancer, 35, 1, 10.1038/bjc.1977.1

Cox, 1972, Regression models and life tables, J R Stat Soc, 34, 187

Aridor, 1999, Integration of endoplasmic reticulum signaling in health and disease, Nat Med, 5, 745, 10.1038/10466

Lee, 2001, The glucose-regulated proteins: stress induction and clinical applications, Trends Biochem Sci, 26, 504, 10.1016/S0968-0004(01)01908-9

Ron, 2002, Translational control in the endoplasmic reticulum stress response, J Clin Invest, 110, 1383, 10.1172/JCI0216784

Little, 1996, Induction of glucose-regulated protein (glucose-regulated protein 78/BiP and glucose-regulated protein 94) and heat shock protein 70 transcripts in the immature rat brain following status epilepticus, Neuroscience, 75, 209, 10.1016/0306-4522(96)00267-9

Outinen, 1998, Characterization of the stress-inducing effects of homocysteine, Biochem J, 332, 213, 10.1042/bj3320213

Fernandez, 2000, Overexpression of the glucose-regulated stress gene GRP78 in malignant but not benign human breast lesions, Breast Cancer Res Treat, 59, 15, 10.1023/A:1006332011207

Chatterjee, 1997, Hypersensitivity to DNA cross-linking agents associated with up-regulation of glucose-regulated stress protein GRP78, Cancer Res, 57, 5112

Sugawara, 1993, Suppression of stress protein GRP78 induction in tumor B/C10ME eliminates resistance to cell mediated cytotoxicity, Cancer Res, 53, 6001

Belfi, 1999, Increased sensitivity of human colon cancer cells to DNA cross-linking agents after GRP78 up-regulation, Biochem Biophys Res Commun, 257, 361, 10.1006/bbrc.1999.0472

Rosell, 2003, Genetic testing for chemotherapy in non-small cell lung cancer, Lung Cancer, 97, 10.1016/S0169-5002(03)00151-X

Youn, 2004, Oncogenic H-Ras up-regulates expression of ERCC1 to protect cells from platinum-based anticancer agents, Cancer Res, 64, 4849, 10.1158/0008-5472.CAN-04-0348

Britten, 2000, ERCC1 expression aa a molecular marker of cisplatin resistance in human cervical tumor cells, Int J Cancer, 89, 453, 10.1002/1097-0215(20000920)89:5<453::AID-IJC9>3.0.CO;2-E

Safaei, 2004, Cross-resistance to cisplatin in cells with acquired resistance to copper, Cancer Chemother Pharmacol, 53, 239, 10.1007/s00280-003-0736-3

Komatsu, 2000, Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance, Cancer Res, 60, 1312

Nakayama, 2004, Prognostic value of the Cu-transporting ATPase in ovarian carcinoma patients receiving cisplatin-based chemotherapy, Clin Cancer Res, 10, 2804, 10.1158/1078-0432.CCR-03-0454

Luo, 2003, Induction of Grp78/BiP by translational block: activation of the Grp78 promoter by ATF4 through and upstream ATF/CRE site independent of the endoplasmic reticulum stress elements, J Biol Chem, 278, 37375, 10.1074/jbc.M303619200

Mandic, 2003, Cisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signaling, J Biol Chem, 278, 9100, 10.1074/jbc.M210284200

Tanabe, 2003, Activating transcription factor 4 increases the cisplatin resistance of human cancer cell lines, Cancer Res, 63, 8592

Li, 1997, Suppression of grp78 core promoter element-mediated stress induction by the dbpA and dbpB (YB-1) cold shock domain proteins, Mol Cell Biol, 17, 61, 10.1128/MCB.17.1.61

Uramoto, 2002, p73 Interacts with c-Myc to regulate Y-box-binding protein-1 expression, J Biol Chem, 277, 31694, 10.1074/jbc.M200266200

Kohno, 2003, The pleiotropic functions of the Y-box-binding protein, YB-1, Bioessays, 7, 691, 10.1002/bies.10300

Shibahara, 2001, Nuclear expression of the Y-box binding protein, YB-1, as a novel marker of disease progression in non-small cell lung cancer, Clin Cancer Res, 7, 3151

Thông tin
Thông tin xuất bản

Lung Cancer

Tập 49

55-62

Thông tin tác giả